⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for small molecule kinase inhibitor

Every month we try and update this database with for small molecule kinase inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the BodyNCT04187456
Solid Tumors
Savolitinib
Midazolam
18 Years - 65 YearsAstraZeneca
Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent LorlatinibNCT05948462
Lung Cancer
Non-small Cell ...
Lorlatinib
Cisplatin or Ca...
Pemetrexed
18 Years - SCRI Development Innovations, LLC
A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With FamotidineNCT04179071
Solid Tumours
Savolitinib
Famotidine
18 Years - 65 YearsAstraZeneca
Lorlatinib in Combination With Chemotherapy in Participants With Metastatic Anaplastic Lymphoma Kinase Positive (ALK+) Non-small Cell Lung Cancer (NSCLC) Who Progressed on Single-agent LorlatinibNCT05948462
Lung Cancer
Non-small Cell ...
Lorlatinib
Cisplatin or Ca...
Pemetrexed
18 Years - SCRI Development Innovations, LLC
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: